Sherri Lee Ferstler Net Worth

The estimated Net Worth of Sherri Lee Ferstler is at least 530 千$ dollars as of 12 August 2024. Sherri Ferstler owns over 1,550 units of Tactile Systems Technology Inc stock worth over 509,747$ and over the last few years Sherri sold TCMD stock worth over 20,259$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Sherri Ferstler TCMD stock SEC Form 4 insiders trading

Sherri has made over 1 trades of the Tactile Systems Technology Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Sherri sold 1,550 units of TCMD stock worth 20,259$ on 12 August 2024.

The largest trade Sherri's ever made was selling 1,550 units of Tactile Systems Technology Inc stock on 12 August 2024 worth over 20,259$. On average, Sherri trades about 517 units every 0 days since 2023. As of 12 August 2024 Sherri still owns at least 38,764 units of Tactile Systems Technology Inc stock.

You can see the complete history of Sherri Ferstler stock trades at the bottom of the page.

What's Sherri Ferstler's mailing address?

Sherri's mailing address filed with the SEC is 3701 WAYZATA BLVD., SUITE 300, MINNEAPOLIS, MN, 55416.

Insiders trading at Tactile Systems Technology Inc

Over the last 8 years, insiders at Tactile Systems Technology Inc have traded over 215,774,039$ worth of Tactile Systems Technology Inc stock and bought 284,300 units worth 3,558,518$ . The most active insiders traders include Zubeen Shroff、Partners V Lp Galen Partner...、Jordan Davis. On average, Tactile Systems Technology Inc executives and independent directors trade stock every 11 days with the average trade being worth of 402,508$. The most recent stock trade was executed by Sherri Lee Ferstler on 12 August 2024, trading 1,550 units of TCMD stock currently worth 20,259$.

What does Tactile Systems Technology Inc do?

tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.

Complete history of Sherri Ferstler stock trades at Tactile Systems Technology Inc

Tactile Systems Technology Inc executives and stock owners

Tactile Systems Technology Inc executives and other stock owners filed with the SEC include:

• Gerald R. Mattys,
  Consultant
• Bryan Rishe,
  Senior Vice President of Sales
• Brent Moen,
  Chief Financial Officer
• Daniel L. Reuvers,
  Pres, CEO & Director
• Bryan F. Rishe,
  Sr. VP of Sales
• Brent A. Moen,
  Chief Financial Officer
• Eric C. Pauls,
  Sr. VP of Sales
• Kristie T. Burns,
  Sr. VP of Marketing & Clinical Affairs
• Peter Soderberg,
  Independent Chairman of the Board
• Richard Nigon,
  Independent Director
• William Burke,
  Independent Director
• Kevin Roche,
  Independent Director
• Cheryl Pegus,
  Independent Director
• Raymond Huggenberger,
  Independent Director
• Mike Piccinino,
  IR Contact Officer
• Jay Stracke,
  Vice President of Reimbursement and Payer Relations
• Peter Schaubach,
  Chief Information Officer
• Daniel Reuvers,
  President, Chief Executive Officer, Director
• Janelle Strop,
  Chief Human Resource Officer
• Thomas F. O'Donnell Jr., M.D.,
  Chief Medical Officer & Member of Vascular Strategic Advisory Board
• Kristie Burns,
  Sr. VP of Marketing & Clinical Affairs
• Jerry Sauber,
  VP of Operations
• Eric Pauls,
  Sr. VP of Sales
• Darren J. Wennen,
  Sr. VP of Commercial Operations
• Thomas F. O'Donnell Jr.,
  Chief Medical Officer
• Juleen F. Krings,
  Chief HR Officer
• Sunday J. Hoy,
  VP & Compliance Officer
• Mark W. Aldridge,
  VP of Operations
• Valerie L. Asbury,
  Director
• Robert J. Folkes,
  Chief Operating Officer
• Zubeen Shroff,
  Director
• Mary E. Anderson,
  Vice President, Reimbursement
• Venture Partners Iii, Llcra...,
  
• Jordan Davis,
  Director
• Partners V Lp Galen Partner...,
  
• Lynn Larson Blake,
  Chief Financial Officer
• Gerald R. Mattys,
  Chief Executive Officer
• Stephen I Shapiro,
  Director
• Venture Partners Iii, Llcra...,
  
• Maggie Thompson,
  VP Payer Rltns & Govt Affr
• Deepti Jain,
  Director
• Boyd Vindell Washington,
  Director
• Kristie Burns,
  Sr. VP Mktg & Clinical Affairs
• Eric Pauls,
  Senior VP, Sales
• David Brent Shafer,
  Director
• Carmen B Volkart,
  Director
• Elaine M. Birkemeyer,
  Chief Financial Officer
• Sherri Lee Ferstler,
  Senior VP, Sales
• Sheri Louise Dodd,
  Chief Executive Officer